QHP Capital completes $1.1bn continuation fund for Azurity Pharmaceuticals

HarbourVest Partners led the transaction with Pantheon Ventures participating as a significant investor.

19 March 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.